The company also provided a broader update on recent hiring initiatives.
PLEASANTON, Calif., April 18, 2022 /PRNewswire/ — Movano Inc. (Nasdaq: MOVE), a healthcare solutions company at the intersection of medical technology and consumer devices, announced the expansion of its management team with the strategic hiring of Chief Marketing Officer (CMO), Tyla Bucher.
Tyla brings over two decades of experience creating and launching integrated global consumer marketing campaigns for leading brands. In her most recent role as Senior Vice President of Marketing for Hydrow, maker of the first home-connected rowing machine, she successfully launched the company’s first full-funnel brand campaign, doubling brand awareness and contributing to its impressive revenue growth. Prior to Hydrow, Tyla held various leadership roles in brand strategy and marketing at Hasbro, where she oversaw the development of the company’s first direct-to-consumer channel, as well as the strategic direction of a $1.5 billion global entertainment brand. Tyla also served as VP of Brand Marketing at Twentieth Century Fox, where she oversaw the execution of strategic multi-channel business plans for all of the studio’s new titles. Additionally, she led the division’s rapid expansion into digital distribution, driving new windowing strategies and creating bespoke cross-platform consumer marketing programs, contributing to the record success of award-winning studio releases. As Movano’s CMO, Tyla will oversee the company’s brand, communications and marketing strategies and work cross-functionally to develop partnerships and sales strategies.
“Since unveiling plans for our first product, the Movano Ring, we have built tremendous momentum and have been very focused on preparing to bring an attractive, intuitive and smart ring to market this year. As we get closer to production, we enlisted Tyla to drive our vision, mature our brand, and lead the tactical marketing efforts that will be critical to launching the Ring and positioning Movano for revenue generation,” said Dr. Jean MastrototaroCEO of Movano Inc. “Tyla brings a strong female perspective, an unparalleled level of creativity and valuable strategic marketing skills to our leadership team which we believe will help connect Movano to consumers and partners and bring to our brand.”
Movano announced its flagship product, the Movano Ring, in December 2021. Designed for women, the Ring and its companion app combine vital health metrics with personalized smart feedback. The ring helps you make the connections between cause and effect and understand the correlation between how you feel and various areas of your health, including activity, sleep and more, by measuring heart rate, heart rate variability, sleep, respiratory rate, temperature, blood oxygen. saturation, steps and calories. Movano plans to add medically validated data to its platform, which caregivers and healthcare professionals can use to help identify and better manage symptoms of chronic conditions.
The Movano Ring is expected to be one of the most affordable healthcare devices on the market and will be available via beta in the second half of 2022.
To support Movano’s continued growth plans and as previously announced, the Company’s Board of Directors has approved the reservation of 2,000,000 shares of common stock to be used exclusively for the grant of equity awards to individuals who were not previously employees of the Company (or following a bona fide period of non-employment), as an inducement to an individual’s entry into employment with the Company within the meaning of the rule 5635(c)(4) of the NASDAQ Listing Rules.
On April 15, 2022, pursuant to the incentive grant plan, Movano granted incentive stock options covering a total of 295,000 common shares to three new non-executive employees. The stock options were granted on April 15, 2022 at an exercise price of $2.54 per share. Stock options vest as follows: one quarter vests on the first anniversary of the grant date and the balance vests in 36 equal monthly installments thereafter. The awards were approved by a majority of the independent members of the Company’s Board of Directors and were granted as incentive materials to new employees entering the Company’s employ pursuant to Rule 5635(c)( 4) from the NASDAQ Marketplace. The Company is making this announcement in accordance with NASDAQ rules.
For more information about Movano, visit www.movano.com.
About Movano Inc.
Founded in 2018, Movano Inc. (NASDAQ: MOVE) develops a platform to deliver targeted healthcare solutions at the intersection of medical technologies and consumer devices. We’re on a mission to empower and inspire you to live a healthier, happier life by combining vital health data with personalized smart feedback in sleek form factors. Movano plans to add medically validated data to its platform that caregivers and medical professionals can use to help you identify, treat, or better manage symptoms of chronic conditions.
This press release contains forward-looking statements regarding our expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on assumptions made by us as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions and events to differ materially from those anticipated. Accordingly, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results; product development and features, product launches, clinical trials and regulatory initiatives; our strategies, positioning and expectations regarding future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and all subsequent Quarterly Reports on Form 10-Q, as well as in our other reports. filed with the Securities and Exchange Commission, including under the heading “Risk Factors”. Any forward-looking statements in this release speak only as of the date of this release. We undertake no obligation to update publicly any forward-looking statements, written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.